Bioventix (LON:BVXP) Shares Pass Above 50-Day Moving Average – Here’s Why

Bioventix PLC (LON:BVXP)’s share price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 2,672.69 ($36.29) and traded as high as GBX 2,850 ($38.70). Bioventix shares last traded at GBX 2,800 ($38.02), with a volume of 2,136 shares.

Bioventix Stock Performance

The firm has a market cap of £149.24 million, a price-to-earnings ratio of 18.43 and a beta of 0.35. The company has a 50 day moving average of GBX 2,672.69 and a 200 day moving average of GBX 2,986.40.

Bioventix (LON:BVXP) last released its earnings results on Monday, March 31st. The biotechnology company reported GBX 72.27 ($0.98) earnings per share (EPS) for the quarter. Bioventix had a return on equity of 69.09% and a net margin of 59.51%. Equities analysts forecast that Bioventix PLC will post 166.3066955 EPS for the current fiscal year.

Bioventix Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, April 25th. Shareholders of record on Thursday, April 10th were issued a dividend of GBX 70 ($0.95) per share. This represents a yield of 2.95%. The ex-dividend date of this dividend was Thursday, April 10th. Bioventix’s dividend payout ratio (DPR) is presently 102.19%.

Insiders Place Their Bets

In other news, insider Bruce Hiscock bought 31 shares of the stock in a transaction on Monday, April 28th. The stock was purchased at an average price of GBX 2,632 ($35.74) per share, for a total transaction of £815.92 ($1,107.98). Corporate insiders own 8.02% of the company’s stock.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.